Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/ medroxyprogesterone acetate in real-world practice Article

publication date

  • April 19, 2023

webpage

published in

keywords

  • 17 beta-Estradiol/micronized progesterone
  • Conjugated equine estrogens/medroxyprogesterone acetate
  • Hormone therapy
  • Menopause
  • Safety
  • Venous thromboembolism

start page

  • 23

end page

  • 31

volume

  • 172